• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • 50 Studies Every Endocrinologist Should Know: Classic Endocrinology

    50 Studies Every Endocrinologist Should Know by Interlandi, John;

    Classic Endocrinology

    Series: Fifty Studies Every Doctor Should Know;

      • GET 10% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice GBP 59.00
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        28 187 Ft (26 845 Ft + 5% VAT)
      • Discount 10% (cc. 2 819 Ft off)
      • Discounted price 25 369 Ft (24 161 Ft + 5% VAT)

    28 187 Ft

    db

    Availability

    Not yet published.

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher OUP USA
    • Date of Publication 17 January 2026

    • ISBN 9780197684702
    • Binding Paperback
    • No. of pages448 pages
    • Size 229x157x25 mm
    • Weight 612 g
    • Language English
    • Illustrations 56 Black and White Ilustrations
    • 0

    Categories

    Short description:

    50 Studies Every Endocrinologist Should Know assembles landmark, evidence-based studies in classic endocrinology to guide readers towards solving thorny endocrine problems. Featuring a diverse range of study types--including RCTs, multicenter trials, observational studies, and meta-analyses--this volume addresses the core issues faced by endocrinologists in clinical practice. Each chapter provides a concise summary of key studies, highlighting results, limitations, and practical implications. The chapters conclude with a list of major take-home points, which collectively form a foundation of Endocrine Principles that can be applied to real-word patient problems.

    More

    Long description:

    50 Studies Every Endocrinologist Should Know assembles landmark, evidence-based studies in classic endocrinology to guide readers towards solving thorny endocrine problems. Featuring a diverse range of study types--including RCTs, multicenter trials, observational studies, and meta-analyses--this volume addresses the core issues faced by endocrinologists in clinical practice. Each chapter provides a concise summary of key studies, highlighting results, limitations, and practical implications. The chapters conclude with a list of major take-home points, which collectively form a foundation of Endocrine Principles that can be applied to real-word patient problems.

    As with all books in the "50 Studies" series, each study was selected using an objective selection criterion that included citations per year, high levels of evidence, clinical studies and trials, and a 3-stage Delphi review by international experts in the field. It is an indispensable reference for fellows, physicians, nurse practitioners, and any primary providers with an interest in endocrinology, as well as those taking both the endocrinology board exam and the Endocrinology, Diabetes, & Metabolism certification exam.

    More

    Table of Contents:

    SECTION 1: Conditions caused by Thyroid Damage
    Chapter 1: Screening for Thyroid Disease in Early Pregnancy and in Pre-Pregnancy
    Chapter 2: Subclinical Hypothyroidism
    Chapter 3: Management of Thyroxine in Non-Ablated Patients with Hypothyroidism
    Chapter 4: Optimal Thyroid Replacement for the Athyreotic Patient
    SECTION 2: Conditions Causing Thyroid Overactivity
    Chapter 5: Antithyroid Drugs vs. Ablation in Community Treatment for Graves’ Disease
    Chapter 6: Optimum Use of Antithyroid Drugs in Hyperthyroidism
    Chapter 7: Risks of I-131 Treatment of Hyperthyroidism
    Chapter 8: Hyperthyroidism caused by Amiodarone (AIT)
    SECTION 3: Focal and Structural Thyroid Disease
    Chapter 9: Selection of Thyroid Nodules to be Biopsied
    Chapter 10: Selection of Patients over 45 for Thyroid Biopsy
    Chapter 11: Molecular Genomic Testing (MGT) for Indeterminate Thyroid Nodules
    Chapter 12: Complication Rate(s) from Thyroidectomy
    Chapter 13: Ablation Techniques for Benign or Hot Nodules
    Chapter 14: Microscopic Papillary Thyroid Carcinoma (mPTC) and Active Surveillance (AS)
    Chapter 15: Optimal Work-up and Surgery for a small, non-metastatic DTCA
    Chapter 16: I-131 Treatment for DTCA
    SECTION 4: Parathyroid Diseases
    Chapter 17: Active Surveillance and/or Medical Therapy for Hyperparathyroidism in Older Patients
    Chapter 18: Preoperative Localization of Sporadic Primary Hyperparathyroidism
    Chapter 19: Quality of Life after Surgery for Mild/Moderate Sporadic Primary Hyperparathyroidism
    Chapter 20: Secondary Hyperparathyroidism, Idiopathic Hypercalciuria, and Bone Density
    Chapter 21: Recurrent and/or Persistent Primary Hyperparathyroidism
    SECTION 5: Metabolic Bone Disease
    Chapter 22: Calcium and Vitamin D Effects on Bone Mass
    Chapter 23: Fracture Prevention in Patients with Low Bone Mass
    Chapter 24: Pretreatment Evaluation for Osteoporosis
    Chapter 25: Evaluation of Fracture Risk in Osteoporosis
    Chapter 26: Osteoporosis and Hip Fracture Prevention
    Chapter 27: Alendronate and Fracture Risk Reduction
    Chapter 28: Hip Fracture in the Elderly with Very Low Bone Density
    Chapter 29: Anabolic Agent(s) for Osteoporosis
    Chapter 30: Glucocorticoid Osteoporosis
    Chapter 31: Osteoporosis in Men
    SECTION 6: Adrenal Conditions
    Chapter 32: The Importance of Recognizing Hyperaldosteronism
    Chapter 33: Effectiveness of Treatment of Hyperaldosteronism
    Chapter 34: Screening for Adrenal Insufficiency
    Chapter 35: Adrenal Incidentalomas
    Chapter 36: Opioid-Induced Endocrine Deficiencies
    Chapter 37: Adrenal Insufficiency from Corticosteroid Treatment
    Chapter 38: Optimal Testing for ACTH-Dependent Hypercortisolism
    SECTION 7: Pituitary Tumors / Hypercortisolism
    Chapter 39: Duration of Medical Treatment of Intrasellar Prolactinomas
    Chapter 40: Acromegaly Treatment-Surgery, Medication, or What?
    Chapter 41: Primary Treatment of Pituitary Hypercortisolism
    Chapter 42: Treatment of Recurrent or Persistent Hypercortisolism
    SECTION 8: Conditions Caused by Testosterone Deficiency
    Chapter 43: Risks of Testosterone Treatment in Older Men
    Chapter 44: Male Obesity Secondary Hypogonadism (MOSH)
    SECTION 9: Conditions Related to Estrogen Deficiency
    Chapter 45: Estrogen Treatment and Cardiovascular Health
    Chapter 46: Estrogen Treatment and Skeletal Health
    Chapter 47: Estrogen + Progestin vs. Estrogen Alone, and Neoplasia
    SECTION 10: Polycystic Ovary Syndrome
    Chapter 48: Optimal Differential Diagnosis of PCOS
    Chapter 49: Optimal Treatment of Hirsutism in PCOS
    Chapter 50: Treatment of Subfertility in PCOS

    More
    0